UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 3, 2017

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)



 

Delaware

(State or other jurisdiction of incorporation)

1-07151

(Commission File Number)

31-0595760

(I.R.S. Employer

Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices)    (Zip code)

 

(510) 271-7000
(Registrant's telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨



 

Item 2.02 Results of Operations and Financial Condition

 

On August 3, 2017, The Clorox Company issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2017. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 7.01 Regulation FD Disclosure

 

Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information.

 

Item 9.01 Financial Statements and Exhibits

 

(d)   Exhibits
 
 

Exhibit        

Description

99.1

Press Release dated August 3, 2017 of The Clorox Company

99.2

Supplemental information regarding financial results      



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

THE CLOROX COMPANY
 

Date: August 3, 2017

By: 

     /s/ Laura Stein

 

     Executive Vice President –
     General Counsel and Corporate Affairs




 

THE CLOROX COMPANY

 

FORM 8-K

 

INDEX TO EXHIBITS

 

Exhibit Description
99.1 Press Release dated August 3, 2017 of The Clorox Company
99.2 Supplemental information regarding financial results


Clorox (NYSE:CLX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Clorox Charts.
Clorox (NYSE:CLX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Clorox Charts.